
MCHP · Nasdaq
Reports Nov 5, 2026.
Consensus is $0.80 EPS for Sep 2026 across 7 estimates, ranging $0.74 to $0.82.
Microchip’s June quarter marked a sharp continuation of its semiconductor recovery. Revenue of $1.485 billion exceeded the company’s $1.456 billion guidance midpoint, rose 38.0% from $1.076 billion a year ago and increased 13.2% sequentially from an implied approximately $1.312 billion in the March quarter. The supplied consensus comparison shows reported EPS of $0.61 versus $0.59 expected, a 3.39% beat. Separately, the release reported GAAP diluted EPS of $0.37 and non-GAAP diluted EPS of $0.76, versus a GAAP loss of $0.09 and non-GAAP EPS of $0.27 in the year-ago quarter.
The defining feature was operating leverage as demand recovered and factories ran more efficiently. GAAP operating income rose to $336.8 million from $32.1 million, and non-GAAP operating margin reached 35.1%, supported by 63.8% non-GAAP gross margin, lower underutilization charges and a $68.6 million year-over-year benefit from lower inventory reserves. Inventory days fell to 175, bookings remained strong with book-to-bill well above one, and PCIe Gen6 design wins doubled sequentially to 12. Cash generation also improved materially, with $511.5 million of operating cash flow and $497.6 million of free cash flow, enabling $170 million of net debt reduction while returning $246.9 million through common dividends. Management expects another 7% to 9% sequential revenue increase in September.
Microchip attributed the sales rebound to customers working through excess inventory, improving end-market demand and new design wins entering production. The recovery was broad rather than concentrated in one product or customer, with every product line and geography increasing year over year. Distribution sell-through improved, distributor inventory declined to 25 days from 26 days at March 31, and bookings remained strong with book-to-bill well above one.
The quarter showed substantial fixed-cost absorption as production recovered. Higher factory utilization, lower underutilization charges and disciplined spending drove the sharp improvement in profitability, although acquired-intangible amortization and restructuring-related items continued to separate GAAP from non-GAAP results.
The earnings recovery translated into stronger cash generation despite continued dividends and only limited capital investment. Microchip is using the recovery to reduce leverage while maintaining its common-stock dividend and selective capacity spending.
Management expects the recovery to continue into the September quarter, with revenue growth and factory utilization providing additional margin leverage. The guidance implies another step-up from the June result rather than a pause after the initial rebound.
Despite the improved operating profile, Microchip remains highly leveraged and carries several potential claims and conversion-related obligations. The filing also identifies a material tax dispute in Malaysia that is not reflected as an immediate cash outflow but could be significant if the company loses.